This HTRF kit enables the cell-based quantitative detection of Total TFEB.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
Feature | Specification |
---|---|
Application | Cell Signaling |
Sample Volume | 16 µL |
This HTRF kit enables the cell-based quantitative detection of Total TFEB.
For research use only. Not for use in diagnostic procedures. All products to be used in accordance with applicable laws and regulations including without limitation, consumption and disposal requirements under European REACH regulations (EC 1907/2006).
TFEB acts as an upstream regulator of macroautophagy, which is a physiological process maintaining cellular homeostasis. It makes TFEB a new therapeutic target for various disorders (ageing related diseases, infectious disease, lysosomal storage disorders, neurodegenerative diseases, or cancers).
Application |
Cell Signaling
|
---|---|
Brand |
HTRF
|
Detection Modality |
HTRF
|
Lysis Buffer Compatibility |
Lysis Buffer 1
Lysis Buffer 2
Lysis Buffer 3
Lysis Buffer 4
|
Molecular Modification |
Total
|
Product Group |
Kit
|
Sample Volume |
16 µL
|
Shipping Conditions |
Shipped in Dry Ice
|
Target Class |
Phosphoproteins
|
Target Species |
Human
|
Technology |
TR-FRET
|
Unit Size |
500 Assay Points
|
The HTRF Total TFEB assay quantifying the expression level of TFEB is entirely plate-based and does not require gels, electrophoresis, or transfer. The assay uses two antibodies, one coupled to a donor fluorophore and the other to an acceptor. The two antibodies are highly specific for a distinct epitope on the protein. In presence of TFEB in a cell extract, the addition of these conjugates brings the donor fluorophore into close proximity with the acceptor, and thereby generates a FRET signal. Its intensity is directly proportional to the concentration of the protein present in the sample, and provides a means of assessing the protein’s expression under a no-wash assay format.
The 2-plate protocol involves culturing cells in a 96-well plate before lysis, then transferring lysates to a 384-well low volume detection plate before the addition of the Total TFEB HTRF detection reagents. This protocol enables the cells' viability and confluence to be monitored.
Detection of total TFEB with HTRF reagents can be performed in a single plate used for culturing, stimulation, and lysis. No washing steps are required. This HTS-designed protocol enables miniaturization while maintaining robust HTRF quality.
HeLa cells were seeded in a 96-well culture-treated plate at 100,000 cells / well in complete culture medium, and incubated overnight at 37 ° C, 5% CO2.The cells were then treated with increasing concentrations of mTOR inhibitors (AZD2014 or PP242) for 1h at 37°C, 5%CO2. After cell lysis with 50 µL of supplemented lysis buffer #4, 16 µL of lysates were transferred into a 384-well low volume white microplate before the addition of 4 µL of the HTRF Total TFEB detection antibodies. The HTRF signal was recorded after an overnight incubation.
As expected, our results showed a dose-dependent decrease in phosphorylated TFEB on Ser211 after mTOR inhibitor treatment, while the Total TFEB expression level was not significantly modulated. In addition, no cytotoxic effects were observed with ATPliteTM assay (Revvity, #601673) in the same experimental conditions (data not shown).
HeLa cells were plated in 96-well plates (20,000 cells/well) and cultured for 24h. The cells were then transfected with siRNAs specific for TFEB as well as with a negative control siRNA. After a 48h incubation, the cells were lysed and 16 µL of lysates were transferred into a 384-well low volume white microplate before the addition of 4 µL of the HTRF Total TFEB detection antibodies.
TFEB siRNA led to a 90% signal decrease compared to the cells transfected with the negative siRNA. In the same experimental conditions, the silencing of the TFEB had no effect on cell proliferation or viability when assessed with ATPliteTM assay.
These results demonstrate the detection specificity of the HTRF Total TFEB kit.
Total TFEB expression levels were assessed with the HTRF Total TFEB kit in different cell lines: THP1, HeLa, HEK293T, and U87-MG.
The cell lines were cultured in T175 flasks in complete culture medium at 37°C, 5% CO2. After a 48h incubation, the cells were lysed with 3 mL of supplemented lysis buffer #4 (1X) for 30 minutes at RT under gentle shaking. 16 µL of each lysate were transferred into a low volume white microplate before the addition of 4 µL of HTRF Total TFEB detection reagents.
THP1 cells were cultured in a T175 flask in complete culture medium at 37°C, 5% CO2. After a 48h incubation, the cells were lysed with 3 mL of supplemented lysis buffer #4 (1X) for 30 minutes at RT under gentle shaking.
Serial dilutions of the cell lysate were performed using supplemented lysis buffer, and 16 µL of each dilution were transferred into a low volume white microplate before the addition of 4 µL of HTRF Total TFEB detection reagents. Equal amounts of lysates were used for a side-by-side comparison between HTRF and Western Blot.
In these conditions, the HTRF Total TFEB assay is 16 times more sensitive than the Western Blot technique.
TFEB (transcriptional factor EB) is a transcription factor which belongs to the MiTF/TFE family. TFEB induces transcription of the genes encoding proteins associated with autophagy and lysosomal biogenesis, via a consensus sequence encountered in more than 96 lysosomal gene promoters (CLEAR motif - Coordinated Lysosomal Expression And Regulation).
TFEB activity is controlled by phosphorylation events which are mediated by different kinases, including AKT, mTOR, and ERK2.
Under nutrient rich conditions, TFEB is phosphorylated by mTOR on Ser 211 and sequestered into the cytosol, whereas under starvation or lysosomal dysfunction, TFEB is dephosphorylated and translocated into the nucleus to promote gene transcription.
TFEB acts as an upstream regulator of macroautophagy, which is a physiological process maintaining cellular homeostasis. It makes TFEB a new therapeutic target for various disorders (ageing related diseases, infectious disease, lysosomal storage disorders, neurodegenerative diseases, or cancers).
Are you looking for resources, click on the resource type to explore further.
Discover the versatility and precision of Homogeneous Time-Resolved Fluorescence (HTRF) technology. Our HTRF portfolio offers a...
We are here to answer your questions.